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Prilokaine bağlı gelişen methemoglobinemi nadir görülen bir du-
rumdur. Bu yazıda epilasyon öncesi kullanılan prilokaine sekonder 
gelişen methemoglobinemi olgusunu sunarak nadir görülen bu 
durumun önemine işaret etmek istiyoruz. Otuz yaşında kadın acil 
servise baş ağrısı, dispne ve siyanoz şikayetleri ile başvurdu. Hasta-
ya beş saat öncesinde bir güzellik merkezinde epilasyon öncesinde 
yaklaşık 1000-1200 mg prilokain subkutan enjeksiyonu yapıldığı 
öğrenildi. Başvuruda kan basıncı 130/73 mmHg, nabız 103/dk, vü-
cut ısısı 37 °C ve solunum sayısı 20/dk olarak kaydedilmişti. Hasta-
nın akral siyanozu belirgindi. Venöz kan gazında methemoglobin 
düzeyi %14.1 olarak ölçüldü. Hastaya 3 g intravenöz askorbik asit 
uygulandı. Tedavi sonrası semptomları gerileyen ve komplikasyon 
geliştirmeyen hasta 48 saat sonra taburcu edildi. Acil servis doktor-
ları, prilokain enjeksiyonu sonrası gelişen dispne ve siyanoz ayırıcı 
tanısında mutlaka methemoglobinemiyi akla getirmelidirler.
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SUMMARY
Prilocaine induced methemoglobinemia is a rare entity. In the pres-
ent paper, the authors aim to draw attention to the importance of 
this rare condition by reporting this case. A 30-year-old female 
presented to Emergency Department with headache, dispnea and 
cyanosis. The patient has a history of 1000-1200 mg of prilocaine 
subcutaneous injection for hair removal at a beauty center, 5 hours 
ago. Tension arterial: 130/73 mmHg, pulse: 103/minute, body tem-
perature: 37 °C and respiratory rate: 20/minute. The patient had ac-
ral and perioral cyanosis. Methemoglobin was measured 14.1% in 
venous blood gas test. The patient treated with 3 gr ascorbic acid 
intravenously. The patient was discharged free of symptoms after 
48 hours of observation. Emergency physician should consider 
methemoglobinemia in presentation of dispnea and cyanosis after 
injection of prilocaine.
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Introduction
Hemoglobin (Hb) is a molecule which carries oxygen from 
respiratory organs to the rest of the body. Hb binds to iron 
in a ferrous (Fe2+) oxidation state under normal conditions. 
However, the existence of oxidative stress is known to trans-
form iron to ferric iron (Fe3+). Upon oxidation, hemoglobin or 
methemoglobin (MetHb) cannot bind to oxygen molecules. 
In methemoglobinemia, the Hb is unable to release oxygen 
effectively to body tissues. While mild forms of methemo-
globinemia can be asymptomatic, cyanosis, tachypnea, 
tachycardia, hypotension, confusion, and even death can 
be seen in the more severe cases.[1] There are three common 
causes of methemoglobinemia, including hemoglobinopa-
thies, hereditary enzyme deficiencies (NADH MetHb reduc-
tase), and exposure to drugs. Interestingly, hemoglobin-
opathies and hereditary enzyme deficiencies (NADH MetHb 
reductase) are the least common causes, whereas exposure 
to drugs is the most common.[2]
Many chemicals and drugs had been reported to cause toxic 
methemoglobinemia, including nitrite, nitrate, chlorate, qui-
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nine, aminobenzene, nitrobenzene, nitrotoluenes, phenac-
etin, chloroquine, dapson, phenytoin, sulphonamides, and 
local anesthetics.[3] Methemoglobinemia, caused by prilo-
caine a local anesthesia is rare.[4] Prilocaine, a derivative of 
toluidine, is an amide local anesthetic and has been shown 
to produce high MetHb levels.[2,5] Because of its rarity, our 
knowledge about treatment use is limited. In this paper, we 
discuss a treatment strategy using ascorbic acid for a patient 
diagnosed with methemoglobinemia by prilocaine. Re-
search targets and strategies to understand best treatment 
strategies will be discussed. 
Case Report
A 30-year-old woman was admitted to emergency depart-
ment (ED) with complaints of tachycardia, headache, dys-
pnea, and cyanosis. It was learned from her history that she 
was anesthetized with 2.5-3 vials (1000-1200 mg?) of prilo-
caine (citanest®) subcutaneously before a laser hair removal 
procedure. Although the severity of the symptoms de-
creased at the time of ED admission compared to the initial 
time point, her symptoms were still ongoing. The patient’s 
medical history was unremarkable. The tension arterial rate 
was 130/73 mmHg, pulse rate was 103/minute, body tem-
perature was 37 °C, and respiratory rate was 20/minute. The 
pulse oximeter measured O2 saturation as 90%, and she had 
acral cyanosis. Electrocardiography revealed sinus tachycar-
dia with a rate of 103/minute. Chest radiograph, complete 
blood counting, renal function tests and electrolytes were 
all in the normal range. Venous blood gas analyses revealed 
MetHb as 14.1%. Despite treatment with 4 L/minute O2, her 
symptoms were still continual. She was admitted to the in-
tensive care unit and 3 grams of ascorbic acid was given in-
travenously. Two hours after treatment, control MetHb was 
measured as 2.4%, and the patient was free of symptoms 
and with no complications. She was discharged as healthy 
upon a 48 hour of follow up period.
Discussion
Prilocaine at therapeutic doses (1-2 mg/kg) can cause lim-
ited methemoglobinemia without cyanosis.[6] The maximum 
safe dose of prilocaine is 8 mg/kg (maximum of 600 mg) as 
a single injection.[2] In this case, 1000-1200 mg of prilocaine 
was administered, in which the limits were highly exceeded. 
The effects of local anesthetic induced methemoglobinemia 
are known and include seizures, respiratory compromise, 
myocardial infarction, shock state, coma, hypoxic encepha-
lopathy, and death. In a retrospective study it was reported 
that most patients with a methemoglobin (≥8%) were symp-
tomatic.[7] 
In methemoglobinemia resulting from chemical substances, 
the first step of treatment is to avoid further exposure. If 
methemoglobinemia is under 20%, spontaneous recovery is 
usually observed after drug avoidance, but treatment may 
be necessary in newborns and infants.[8] Methylene blue, 
ascorbic acid, and riboflavin have been suggested as treat-
ment modalities.[9] Methylene blue should be administered 
1-2 mg/kg intravenously in five minutes, and repeated one 
hour later if adequate improvement is not observed.[10] It is 
contraindicated in patients with glucose 6 phosphate dehy-
drogenase deficiency because administration of methylene 
blue can cause aggravation of methemoglobinemia, chest 
pain, cyanosis and hemolytic anemia.[3] In such cases, ascor-
bic acid can be considered as an antidote.[11,12] Hyperbaric 
oxygen therapy and exchange transfusion is another option 
if MetHb level is over 70%.
Ascorbic acid reduces MetHb by a non-enzymatic processes 
in animal and human erythrocytes in vitro, which makes 
ascorbic acid a candidate for treatment of methemoglo-
binemia.[13,14] It is most commonly used orally in long term 
treatment of patients with hereditary methemoglobinemia.
[1] Although, methylene blue can be a first choice treatment 
of methemoglobinemia, if there is limited experience in 
the use of ascorbic acid in toxic methemoglobinemia.[15] Al-
though MetHb was measured relatively less (14.1%) in the 
present case, there was an indication of antidote therapy 
due to the patient being symptomatic. In addition, ascorbic 
acid was chosen because a limited supply of methylene blue 
in the hospital. After administration of ascorbic acid, MetHb 
was measured as 2.4% and she was asymptomatic. Aydogan 
et al. reported that two patients with methemoglobinemia 
recovered after ascorbic acid administration.[13] Tekbas et al. 
also reported an improvement in a patient with combined 
treatment of methylene blue and ascorbic acid caused by 
methemoglobinemia due to prilocaine given before intra-
vascular laser therapy.[16]
Conclusion
Methemoglobinemia resulting from the usage of prilocaine 
within and out of hospital is a major concern. Methemoglo-
binemia should be considered in patients who had cyanosis 
after local anesthetic administration. In cases which methy-
lene blue could not be used as an antidote, ascorbic acid can 
be a safe alternative.
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